- Home
- STRT vs CLYM Comparison
STRT vs CLYM Comparison
Compare STRT & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRT
- CLYM
- Stock Information
- Founded
- STRT 1908
- CLYM 2018
- Country
- STRT United States
- CLYM United States
- Employees
- STRT N/A
- CLYM N/A
- Industry
- STRT Auto Parts:O.E.M.
- CLYM
- Sector
- STRT Consumer Discretionary
- CLYM
- Exchange
- STRT Nasdaq
- CLYM NYSE
- Market Cap
- STRT 172.2M
- CLYM 201.7M
- IPO Year
- STRT 1995
- CLYM 2021
- Fundamental
- Price
- STRT $39.99
- CLYM $1.95
- Analyst Decision
- STRT
- CLYM
- Analyst Count
- STRT 0
- CLYM 0
- Target Price
- STRT N/A
- CLYM N/A
- AVG Volume (30 Days)
- STRT 16.5K
- CLYM 667.9K
- Earning Date
- STRT 02-06-2025
- CLYM 11-12-2024
- Dividend Yield
- STRT N/A
- CLYM N/A
- EPS Growth
- STRT N/A
- CLYM N/A
- EPS
- STRT 3.94
- CLYM N/A
- Revenue
- STRT $541,412,000.00
- CLYM N/A
- Revenue This Year
- STRT $1.94
- CLYM N/A
- Revenue Next Year
- STRT $4.24
- CLYM N/A
- P/E Ratio
- STRT $10.15
- CLYM N/A
- Revenue Growth
- STRT 6.58
- CLYM N/A
- 52 Week Low
- STRT $21.05
- CLYM $1.73
- 52 Week High
- STRT $44.27
- CLYM $11.55
- Technical
- Relative Strength Index (RSI)
- STRT 48.52
- CLYM N/A
- Support Level
- STRT $37.45
- CLYM N/A
- Resistance Level
- STRT $39.97
- CLYM N/A
- Average True Range (ATR)
- STRT 1.26
- CLYM 0.00
- MACD
- STRT -0.08
- CLYM 0.00
- Stochastic Oscillator
- STRT 53.36
- CLYM 0.00
About STRT STRATTEC SECURITY CORPORATION
Strattec Security Corp designs develops, manufactures, and markets mechanical locks, electronically enhanced locks, and keys. It also produces ignition lock housings; and access control products, including latches, power sliding door systems, and door handles. Strattec ships products to customer locations in the United States, Canada, Mexico, Europe, South America, Korea, and China, and provides full-service aftermarket support. Strattec also supplies products for the heavy truck and recreational vehicle markets, as well as precision, die castings.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.